| Q37025291 | A randomised controlled trial comparing the effect of adjuvant intrathecal 2 mg midazolam to 20 micrograms fentanyl on postoperative pain for patients undergoing lower limb orthopaedic surgery under spinal anaesthesia |
| Q36625540 | A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain |
| Q35921545 | An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception. |
| Q41543370 | Compatibility and stability of morphine sulphate and naloxone hydrochloride in 0.9% sodium chloride for injection. |
| Q24658384 | Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates |
| Q36008808 | Effects of butorphanol on morphine-induced itch and analgesia in primates. |
| Q52603584 | Efficacy of Nalbuphine with Flurbiprofen on Multimodal Analgesia with Transverse Abdominis Plane Block in Elderly Patients Undergoing Open Gastrointestinal Surgery: A Randomized, Controlled, Double-Blinded Trial. |
| Q43007018 | Intrathecal opioid medication for perioperative analgesia in severely handicapped children undergoing spinal operations |
| Q35659494 | Neuraxial opioid-induced itch and its pharmacological antagonism |
| Q36993379 | Pathophysiology and management of opioid-induced pruritus. |
| Q35358687 | Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus |
| Q35882922 | Pharmacology of nonsteroidal antiinflammatory drugs and opioids |
| Q34582590 | Pilot study of continuous co-infusion of morphine and naloxone in children with sickle cell pain crisis |
| Q33595205 | The effect of naloxone treatment on opioid-induced side effects: A meta-analysis of randomized and controlled trails |